Batoclimab

巴托利单抗

Report date: 2026/04/29 20:02:18

Base Information

Drug NameBatoclimab
Drug Alias Nameanti-hFcRn mAbs - HanAll BioPharmaanti-hFcRn mAbsAnti-FcRn monoclonal antibodyRVT-1401HL-161BKN +[9] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionImmunomodulatorsIgG receptor FcRn large subunit p51 antagonists
TargetsIgG receptor FcRn large subunit p51
Therapy Area/IndicationsPurpura, Thrombocytopenic, IdiopathicPurpura, ThrombocytopenicAnemia, Hemolytic, Autoimmune +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumBulgariaCanada +[33] 
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesHanall
China Registration ClassN/A

Develop Information

Active CompaniesDragon Merit Holdings LtdHarbour BioMed (Suzhou) Co LtdHarbour Biomed +[9] 
Inactive CompaniesN/A
Active IndicationsPurpura, Thrombocytopenic, IdiopathicPurpura, ThrombocytopenicLupus Nephritis +[8] 
Inactive IndicationsAnemia, Hemolytic, Autoimmune

Other Information

ATC CodeN/A
Related LinksN/A